Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-22-047748

Chief Scientific Officer sold 43,248 shares at $11.22 ($485,221)

  • Chief Scientific Officer acquired 43,248 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kanner Steven · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-25 Exercise or conversion : show line 1 in the form +43,248 $2.69 $116,337 345,307 D
2022-08-25 Sale : show line 2 in the form −43,248 $11.22 $485,221 302,059 D
Open-market sales · 43,248 sh · avg $11.22 · $485,221

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-25 Exercise or conversion : show line 3 in the form Option to purchase Common Stock −43,248 73,601 D
Loading xslF345X03/doc4.xml…